Results 151 to 160 of about 55,801 (184)
Postoperative adjuvant management in hepatocellular carcinoma: A review of therapeutic efficacy and prognostic outcomes. [PDF]
World J HepatolLiu F, Zhang J, Li K.
europepmc +1 more source
Long-term survival after local immunotherapy for malignant gliomas: a retrospective study with 20 years follow-up. [PDF]
BMC ImmunolDuan H +12 more
europepmc +1 more source
Long-term tumor suppression in cholangiocarcinoma using cytokine-induced killer cell therapy and high-dose vitamin C: a case report. [PDF]
Korean J Clin OncolKim K, Wang H, Lee J, Yeom C.
europepmc +1 more source
The potential role of cannabidiol (CBD) in lung cancer therapy: a systematic review of preclinical and clinical evidence. [PDF]
Cancer Cell IntEsmaeli M, Dehghanpour Dehabadi M.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Nature Plants, 2018
The stem cell niche in plant shoots is maintained by carefully orchestrated feedback between a series of CLAVATA (CLV) receptors and their ligand CLV3, and the transcription factor WUSCHEL. A new clade of co-receptors, CLV3-insensitive receptor kinases (CIKs), provides an important missing link in CLV signalling.
Fang, Xu, David, Jackson
openaire +2 more sources
The stem cell niche in plant shoots is maintained by carefully orchestrated feedback between a series of CLAVATA (CLV) receptors and their ligand CLV3, and the transcription factor WUSCHEL. A new clade of co-receptors, CLV3-insensitive receptor kinases (CIKs), provides an important missing link in CLV signalling.
Fang, Xu, David, Jackson
openaire +2 more sources
Security Analysis of CIKS-128 and CIKS-128H Using Key Schedule Weaknesses
International Symposium on Computer Science and its Applications, 2008In this paper, we show that CIKS-128 and CIKS-128H are vulnerable to related-key differential attacks. We first describe how to construct their full-round related-key differential characteristics with high probabilities and then we exploit them to break the full-round CIKS-128 and CIKS-128H with 244,and 248 data and time complexities, respectively ...
Changhoon Lee +5 more
openaire +1 more source
Clinical trials on CIK cells: first report of the international registry on CIK cells (IRCC)
Journal of Cancer Research and Clinical Oncology, 2010Recently, a subset of natural killer T lymphocytes termed "cytokine-induced killer (CIK) cells" has been described. To build an international registry, we collected the clinical data and treatment of patients with cancer using CIK cells from the literature and the respective investigators.
C, Hontscha +4 more
openaire +2 more sources
Canadian Theatre Review, 1997
Caution: Copyright 1997 by Rachael Van Fossen and Darrel Wildcat. This play is fully protected under the copyright laws of Canada and all other countries of the Copyright Union. Changes to the script are expressly forbidden without the written consent of Darrel Wildcat and Rachael Van Fossen.
Rachael Van Fossen, Darrel Wildcat
openaire +1 more source
Caution: Copyright 1997 by Rachael Van Fossen and Darrel Wildcat. This play is fully protected under the copyright laws of Canada and all other countries of the Copyright Union. Changes to the script are expressly forbidden without the written consent of Darrel Wildcat and Rachael Van Fossen.
Rachael Van Fossen, Darrel Wildcat
openaire +1 more source
Cancer Immunology, Immunotherapy, 2020
Adjuvant cytokine-induced killer (CIK) cell immunotherapy has shown potential in improving the prognosis of hepatocellular carcinoma (HCC) patients after curative resection. However, whether an individual could obtain survival benefit from CIK cell treatment remains unknown. In the present study, we focused on the characteristics of CIK cells and aimed
Qiu-Zhong Pan +11 more
openaire +2 more sources
Adjuvant cytokine-induced killer (CIK) cell immunotherapy has shown potential in improving the prognosis of hepatocellular carcinoma (HCC) patients after curative resection. However, whether an individual could obtain survival benefit from CIK cell treatment remains unknown. In the present study, we focused on the characteristics of CIK cells and aimed
Qiu-Zhong Pan +11 more
openaire +2 more sources
DC-CIK as a widely applicable cancer immunotherapy
Expert Opinion on Biological Therapy, 2020Introduction: Immunotherapy is now a standard treatment for many malignancies. Although immune checkpoint inhibition has demonstrated substantial efficacy by enhancing T cell activation and function in the tumor microenvironment, adoptive transfer of T and NK cell products promises to provide activated cells capable of immediate and direct tumor ...
Shuo, Wang +5 more
openaire +2 more sources